Search research articles
Contact Us
Filters
Showing results (431-440 of 548) with videos related to
Page
of 55
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
April 28, 2015
Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A
G Young, J Mahlangu, R Kulkarni, et al.
Cellular Immunology
|
January 18, 2016
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice
Sriram Krishnamoorthy, Tongyao Liu, Douglas Drager, et al.
The New England Journal of Medicine
|
January 2, 2020
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
K John Pasi, Savita Rangarajan, Nina Mitchell, et al.
The American Journal of Pathology
|
November 1, 1994
Keratinocyte growth factor causes cystic dilation of the mammary glands of mice. Interactions of keratinocyte growth factor, estrogen, and progesterone in vivo
E S Yi, A A Bedoya, H Lee, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
February 1, 1994
A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers
T A Mustoe, N R Cutler, R M Allman, et al.
Genes & Development
|
December 1, 1993
Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1
D F Pierce, M D Johnson, Y Matsui, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 19, 2024
Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy
Wolfgang Miesbach, Barbara Konkle, Pratima Chowdary, et al.
Military Medicine
|
September 9, 2017
Essential Medications for Patients With Suspected or Confirmed Ebola Virus Disease in Resource-Limited Environments
William F Pierce, Selena D Ready, John Tyson Chapman, et al.
British Journal of Haematology
|
September 12, 2014
Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates
Jerry Powell, Amy Shapiro, Margaret Ragni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 22, 2017
Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A
A D Shapiro, J N Mahlangu, D Perry, et al.
Page
of 55
Search research articles
Search
Showing results (431-440 of 548) with videos related to
Sort By:
Page
of 55
Journal of Thrombosis and Haemostasis : JTH
|
April 28, 2015
Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A
G Young, J Mahlangu, R Kulkarni, et al.
Cellular Immunology
|
January 18, 2016
Recombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A mice
Sriram Krishnamoorthy, Tongyao Liu, Douglas Drager, et al.
The New England Journal of Medicine
|
January 2, 2020
Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A
K John Pasi, Savita Rangarajan, Nina Mitchell, et al.
The American Journal of Pathology
|
November 1, 1994
Keratinocyte growth factor causes cystic dilation of the mammary glands of mice. Interactions of keratinocyte growth factor, estrogen, and progesterone in vivo
E S Yi, A A Bedoya, H Lee, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
February 1, 1994
A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers
T A Mustoe, N R Cutler, R M Allman, et al.
Genes & Development
|
December 1, 1993
Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1
D F Pierce, M D Johnson, Y Matsui, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 19, 2024
Recommendations for a minimum data set for monitoring gene therapy in hemophilia: communication from the ISTH SSC Working Group on Gene Therapy
Wolfgang Miesbach, Barbara Konkle, Pratima Chowdary, et al.
Military Medicine
|
September 9, 2017
Essential Medications for Patients With Suspected or Confirmed Ebola Virus Disease in Resource-Limited Environments
William F Pierce, Selena D Ready, John Tyson Chapman, et al.
British Journal of Haematology
|
September 12, 2014
Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates
Jerry Powell, Amy Shapiro, Margaret Ragni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 22, 2017
Treatment of bleeding episodes with recombinant factor VIII Fc fusion protein in A-LONG study subjects with severe haemophilia A
A D Shapiro, J N Mahlangu, D Perry, et al.
Page
of 55